(LactMed) - GlossaryLactMed Selected ReferencesDrugs and Lactation Database (LactMed) - About Dietary SupplementsBreastfeeding LinksRelated informationPMCPubChem SubstancePubMedSimilar articles in PubMedReview Lovastatin.[Drugs and Lactation Database (...]In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.[J Pharm Pharmacol. 1985]Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.[J Pharmacol Exp Ther. 2005]Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine.[Biochem Pharmacol. 1982]Review Simvastatin.[Drugs and Lactation Database (...]See reviews...See all...Recent ActivityClearTurn
measures include 30- and 90-day mortality. An embedded pharmacokinetics and pharmacodynamics study investigates plasma concentrations of physostigmine and its metabolite eseroline. Further analyses will contribute to our understanding of the role of various cytokines in the pathophysiology of human sepsis. A computer-generated list is used for block randomization. This randomized, controlled, monocentric
, eseroline, benserazide, and pyrogallol induced H2O2 in cell culture media independent of cells. However, another compound, menadione, induced H2O2 in a manner largely dependent on the MDA-MB-231 breast cancer cells used in this study, which is consistent with its known mechanism of inducing ROS through intracellular redox cycling. 1 mM pyruvate, as well as catalase, reduced the H2O2 in culture wells with each ROS inducer tested but it only reduced the cytotoxicity of cell-independent inducers. It reduced the cytotoxicity of benserazide and pyrogallol >10-fold and of eseroline about 2.5-fold, but had no effect on menadione cytotoxicity. From this data, it was concluded that depending on the mechanism of ROS induction, whether intra- or extracellular, a ROS-quenching medium component such as pyruvate